Same-day consultations available at select locations
Clinical trial data from large cardiovascular outcome studiesincluding LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide)have not demonstrated increased fracture risk among patients taking GLP-1 receptor agonists compared with placebo
How Much Does Semaglutide Cost Without Insurance in 2026
What the Community Reports Prior authorization threads are among the most active and frustrating discussions in GLP-1 communities
Lauren A Jones, Daniel I Brierley, GLP-1 and the Neurobiology of Eating Control: Recent Advances, Endocrinology , Volume 166, Issue 2, February 2025, bqae167, Gabe MBN, Breitschaft A, Knop FK, Hansen MR, Kirkeby K, Rathor N, Adrian CL
Spiers PA 1 , Myers D, Hochanadel GS, Lieberman HR, Wurtman RJ